E

Emcure Pharmaceuticals Ltd

PharmaceuticalsSmallcap

About the company

Emcure Pharmaceuticals is engaged in developing, manufacturing and marketing a range of pharmaceutical products across several therapeutic areas.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 6 analysts offering recommendations for Emcure Pharmaceuticals Ltd

83%

Buy

17%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio34.8941.17
PB Ratio6.956.06
Dividend Yield0.48%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions